# A Study to Assess the Drug Absorption Into the Blood After Administration of 3 Doses of AZD5718

> **NCT04087187** · PHASE1 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 14 (actual)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DRUG:** Treatment A
- **DRUG:** Treatment B
- **DRUG:** Treatment C

## Key facts

- **NCT ID:** NCT04087187
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-09-20
- **Primary completion:** 2019-10-31
- **Final completion:** 2019-10-31
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2019-11-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04087187

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04087187, "A Study to Assess the Drug Absorption Into the Blood After Administration of 3 Doses of AZD5718". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04087187. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*